Melanogenuria: laboratory evaluation of the qualitative Thormählen and ferric chloride tests and their clinical utility.
Malignant melanoma, a disease that is increasing in occurrence and medical concern, is characterized by the excretion of melanogens. Two qualitative tests are recommended for melanogen detection, the Thormählen test and the ferric chloride test. We evaluated the laboratory and clinical performance of these tests by subsequently re-evaluating 201 urine samples that had been submitted for routine melanogen analysis. We used (a) Thormählen, (b) ferric chloride, (c) small-scale thin-layer chromatography, and (d) spectrophotometry. Nearly 30% of Thormählen test results were equivocal. The ferric chloride test was of no value in itself or in categorizing equivocal Thormählen results as positive or negative. The small-scale chromatography was irreproducible. Prompt scanning of the Thormählen reaction product was helpful in classifying equivocal results. History review of 121 histopathologically diagnosed melanoma patients indicated that these qualitative assays were of no clinical value in the diagnosis or monitoring of melanoma patients.
Scott
R E
RE
Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN 55905.
Ward
V L
VL
Grinstead
G F
GF
Stevens
B S
BS
Wilson
D M
DM
D002712:Chlorides; D002855:Chromatography, Thin Layer; D005290:Ferric Compounds; D005292:Ferricyanides; D005295:Ferrocyanides; D006801:Humans; D007211:Indoles / Q000652:urine*; D008545:Melanoma / Q000652:urine*; D009599:Nitroprusside; D013053:Spectrophotometry
D002712:Chlorides; D005290:Ferric Compounds; D005292:Ferricyanides; D005295:Ferrocyanides; D007211:Indoles; C009904:melanogen; D009599:Nitroprusside; C000170:ferric ferrocyanide; C024555:ferric chloride